It is estimated that approximately two million fracture-fixation devices (intrame-dultory nails, external-fixation pins, plates, and screws) and about 600,000 joint prosthesis are inserted annually in the United States.1 Projected infections of joint prosthesis (average rate of 2%) is 12,000 and fracture-fixation devices (average 5%) is 1,000,000 annually. Infections of these orthopedic devices causes substantial morbidity and health care expenditure, with an estimated average cost for combined medical and surgical treatment of US$30,000 for an infected prosthesis, and US $15,000 for an infected fracture-fixation device.1 Hence a conservative estimate of US$1.8 billion is spent annually for the management of infected orthopedic implants in the United States.
Although progress has been made in the last decade on the pathogenesis of this biofilm infection, there is still considerable debate and lack of standardization on the diagnosis, methods to establish the bacteriology and management. Despite the enormity of the problems posed by these orthopedic implant infections in developed countries, there is a lack of proper controlled, randomized trials on medical and surgical therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Darouiche, R.O. (2004) Treatment of infections associated withsurgical implants. N Engl J Med 350:1422–1429.
NIH Consensus Development Panel on Total Hip Replacement (1995) NIH consensus conference: total hip replacement. JAMA 273:1950–1956.
Harris, W.H., Sledge, C.B. (1990) Total hip and total knee replacement. N Engl J Med 323:801–807.
Sperling, J.W., Kozak, T.K., Hanssen, A.D., Cofield, R.H. (2001) Infection after shoulder arthroplasty. Clin Ortho 382:206–216.
Murdoch, D.R., Roberts, S.A., Fowler, V.G. Jr., Shah, M.A., Taylor, S.C., Morris, A.J., Corey, G.R. (2001) Infection of orthropedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 32:647–649.
Ainscow, D.A., Denham, R.A., (1984) The risk of hematogenous infection in total joint replacements. J Bone Joint Surg Br 66:580–582.
Schmalzried, T.P., Amstutz, H.C., Au, M.K., Dorey, F.J. (1992) Etiology of deep sepsis in total hip arthroplasty: the significance of hematogenous and recurrent infections. Clin Orthop 280:200–207.
Zimmerli, W., Trompuz, A., Ochsner, P.E. (2004) Prosthetic joint infections. N Engl J Med 351:1645–1654.
Trampuz, A., Steckelberg, J.M., Osmon, D.R., Cockervill, F.R., Hanssen, A.D., Patel, R. (2003) Advances in the laboratory diagnosis of prosthetic joint infection. Rev Med Microbiol 14:1–14.
Pandey, R., Berandt, A.R., Athanason, N.A. (2000) Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. Arch Orthop Trauma Surg 120:570– 574.
Spangehl, M.J., Masri, B.A., O'Connell, J.X., Duncan, C.P. (1999) Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 81:672–683.
Panousis, K., Grigoris, P., Butcher, I., Rana, B., Reilly, J.H., Hamblen, D.L. (2005) Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases. Acta Orthop 76:341–346.
Neut, D., van Horn, J.R., van Kooten, T.G., van der Mei, H.C., Busschet, H.J. (2003) Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop Related Res 413:261–268.
Tunney, M.M., Patrick, S., Gorman, S.P., Sean, P., Nixon, J.R., Anderson, N., Davis, R.J., Hanna, D., Ramage, G. (1998) Improved detection of infection in hip replacements: a currently underestimated problem. J Bone Joint Surg Br 80:568–572.
Trampuz, A., Piper, K.E., Hanssen, A.D., Osmon, D.R., Cockerill, F.R., Steckelberg, J.M., Patel, R. (2006) Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol 44:628–631.
Trampuz, A., Piper, K.E., Jacobson, M.J., Hanssen, A.D., Unni, K.K., Osman, D.R., Mandrekar, J.W., Cockerill, F.R., Steckelberg, J.M., Greenleaf, J.F., Patel, R. (2007) Sonication of removed hip and knee prosthesis for diagnosis of infection. N Engl J Med 357:654–663.
Walvogel, F.A. (2007) Ultrasound – now also for microbiologists? (Editorial). N Engl J Med 357:705–706.
Perdreau-Remington, F., Stefanik. D., Peters, G., Ludwig, C., Rutt, J., Wenzel, R., Pulverer, G. (1996) A four-year prospective study on microbial ecology of explanted prosthetic hips in 52 patients with “aseptic” prosthetic joint loosening. Eur J Clin Microbiol Infect Dis 15:160– 165.
Tiggers, S. Stiles, R.G., Roberson, J.R. (1994) Appearance of septic hip prosthesis on plain radiographs. AJR Am J Roentgenol 163:377–380.
Smith, S.L., Wastie, M.L., Forster, I. (2001) Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin. Radiol. 56:221–224.
Vicente, A.G., Almoguerra, M., Alonso, J.C., Hefferman, A.J., Gomez, A., Contreras, P.I., Martin-Comin, J. (2004) Diagnosis of orthopedic infection in clinical practice using Tc-99 sulesomab (antigranulocyte monoclonal antibody fragment Fab'2). Clin Nuclear Med 29:781–785.
Pakos, E.E., Trikalinos, T.A., Fotopoulos, A.D., Ioannidis, J.P. (2007) Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labelled monoclonal antibodies – a meta-analysis. Radiology 242:101–108.
Lowe, C., Marwin, S.E., Tomas, M.B., Krauss, E.S., Tronco, G.G., Bhargava, K.K., Nichols, K.J., Palestro, C.J. (2004) Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labelled leukocyte/99mTc-sulfur colloid marrow imaging. J Nuclear Med 45:1864–1871.
Lowe, C., Pugliese, P.V., Agriyie, M.O., Tomas, M.B., Marwin, S.E., Palestro, C.J. (2000) Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging 3:159
Reinartz, P., Mumme T., Hermanns, B., Cremerius, U., Wirtz, D.C., Schaefer, W.M., Niethard, F.U., Buell, U. (2005) Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning. J Bone Joint Surg Brit 87:465–470.
Schiesser, M. Stumpe, K.D.M., Trentz, O., Kossmunn, T., Von Schulthess, G.K. (2003) Detection of metallic implant-associated infections with FDG PET in patients with trauma: correlation with microbiologic results. Radiology 226:391–398.
Wirtz, D.C., Heller, K.D., Miltner, O., Zilkens, K.W., Wolff, J.M. (2000) Interleukin-6: a potential inflammatory marker after total joint replacement. Int Orthop 24:194–196.
Dicesare, P.E., Chang, E., Preston, C.F., Liu, C.J. (2005) Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg Am 87:1921–1927.
Panday, R., Drakoulakis, E., Athanasou, N.A. (1999) An assessment of the histological criteria used to diagnose infection in hip revision arthroplasty tissues. J Clin Path 52:118–123.
Banit, D.M., Kaufer, H., Hartford, J.M. (2002) Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop Related Res 401:230–238.
Giulieri, S.G., Graber, P., Ochsner, P.E., Zimmerli, W. (2004) Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32:222– 228.
Trampuz, A., Widmer, A.F. (2006) Infections associated with orthopedic implants. Curr Opin Infect Dis 19:349–356.
Deyo, R.A., Nachermson, A., Mirza, S.K. (2004) Spinal fusion surgery – the case for restraint. N Engl J Med 350:722–726.
Kowalski, T.J., Berbari, E.F., Huddleston, P.M., Steckelberg, J.M., Mandrekar, J.N., Osmon, D.R. (2007) The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin Infect Dis 44:913–920.
Wymenga, A.B., van Horn, J.R., Theeuswes, A., Muytjens, H.L., Slaoff, T.J. (1992) Perioperative factors associated with septic arthritis after arthroplasty. Prospective multi-center study of 362 knee and 2651 hip operations. Acta Orthop Scand 63:665–671.
Berbari, E.F., Hanssen, A.D., Duffy, M.C., Steckelberg, J.M., Ilstrup, D.M., Harmsen, W.S., Osmon, D.R. (1998) Risk factors for prosthetic joint infection: case control study. Clin Infect Dis 27:1247–1254.
Culver, D.H., Horan, T.C., Gaynes, R.P., Martone, W.J., Jarvis, W.R., Emori, T.G., Banerjee, S.N., Edwards, J.R., Henderson, T.S. (1991) Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 91 (Suppl 3B):1525–1575.
Jeys, L.M., Grimer, R.J., Carter, S.R., Tillman, R.M. (2005) Periprosthetic infection in patients treated for an orthopedic oncological condition. J Bone Joint Surg (Am) 87A:842–849.
Ahnfelt, L., Herberts, P. Malchau, H., Anderson, G.B. (1990) Prognosis of total hip replacement. A Swedish multicenter study of 4664 revisions. Acta Orthop Scand 238:1–26.
Kalmeijer, M.D., van Nieuwland-Bollen E., Bogaers-Hofman, D., de Baere, G.A.J., Kluytmans, J.A.J (2000) Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21:319–323.
Katz, J.N., Losina, E., Barrett, J., Phillips, C.B., Mahomed, N.N., Lew, R.A., Guadagoni, E., Harris, W.H., Poss, R., Baron, J.A. (2001) Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg (AM) 83A:1622–1629.
Christodoulou, A.G., Givissis, P., Symeonidis, P.D., Korataglis, D., Pournaras, J. (2006) Reduction of post-operative spinal infections based on etiological protocol. Clin Orthop Related Res 444:107–113.
Stewart, P.S., Costerton, J.W. (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138.
Donlan, R.M., Costerton, J.W. (2002)Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193.
Widmer, A.F., Frei, R., Rajacic, Z., Zimmerli, W. (1990). Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 162:96–102.
Norden, C.W. (1983) Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents. Rev Infect Dis 5 (3):s491–s494.
Andriole, V.T., Nagel, D.A., Southwick, W.O. (1973) A paradigm for human chronic osteomyelitis. J Bone Joint Surg Am 55:1511–1515.
Passl, R., Mÿller, C., Zienlinski, C., Eibl, M.M. (1984) A model of experimental post-traumatic osteomyelitis in guinea pigs. J Trauma 24:323–326.
Worlock, P., Slack, R., Harvey, L., Mawhinney, R. (1988) An experimental model of post-traumatic osteomyelitis in rabbits. Br J Exp Pathol 69:235–244.
Southwood, R.T., Rice, J.L., McDonald, P.J., Hakendorf, P.H., Rozenbilds, M.A. (1985) Infection in experimental hip arthroplasties. J Bone Joint Surg Br 37:229–231.
Belmatoug, N., Crèmieux, A.C., Bleton, R., Volk, A., Saleh-Mghir, A., Grossin, M., Garry, L., Carbon, C. (1996) A new model of experimental prosthetic joint infection due to methicillinresistant Staphyloccus aureus: a microbiologic, histopathologic and magnetic resonance imaging characterization. J Infect Dis 174:414–417.
Crimieux, A.C., Saleh-Mghir, A., Bleton, R., Manteau, M., Belmatoug, N., Massias, L., Garry, L., Sales, N., Maziere, B., Carbon, C. (1996) Efficacy of sparfloxacin and autoradiography diffusion pattern of [14C] sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection. Antimicrobial Agents Chemother 40:2111–2116.
Saleg-Mghir, A., Cremieux, A.C., Bleton, R., Manteau, M., Massias, L, Garry, L., Sales, N., Maziere, B., Carbon, C. (1996) Autoradiographic of 14C-teicoplanin and efficacy of teichoplanin in an experimental staphylococcal infection. In Program and abstracts of the 36th ICAAC (New Orleans) [abst. A38]: Am Society Microbiol, Washington, DC.
Blaser, J., Vergeres, P., Widmer, A.F., Zimmerli, W. (1995) In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 39:1134–1139.
Archer, G.L., Johnston, J.L., Vasquez, G.I., Haywood III, H.B. (1983) Efficacy of antibiotic combinations including rifampicin against methicillin-resistant Staphylococcus epidermidis in vitro and in vivo studies. Rev Infect Dis 5(3):s538–s547.
Lowry, F.D., Wexler, M.A., Steigbigel, N.H. (1982) Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis. J Lab Clin Med 100:94–104.
Eerenberg, J.P., Patka, P., Haarman, H.J., Dwars, B.J. (1994) A new model for post-traumatic osteomyelitis in rabbits. J Invest Surg 7:453–465.
Zimmerli, W., Widmer, A.F., Blatter, M., Frei, R., Ochsner, P.E. for the Foreign-Body Infection (FBI) Study Group (1998). Role of rifampin for treatment of orthopedic implantrelated staphylococcal infections: a randomized controlled trial. Foreign Body Infection (FBI) Study Group. JAMA 279:1537–1541.
Trebse, R., Pisot, V., Trampuz, A. (2005) Treatment of retained implants. J Bone Joint Surg Br 87:249–256.
Tattevin, P., Cremieux, A.C., Pottier, P., Huten, D., Carbon, C. (1999) Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 29:292–295.
Brandt, C.M., Sistrunk, W.W., Duffy, M.C., Hanssen, A.D., Stecklberg, J.M., Ilstrup, D.M., Osmon, D.R. (1997) Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24:914–919.
Tsukayama, D.T., Wicklund, B., Gustilo, R.B. (1991) Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 14:841–844.
Tsukuyama, D.T., Estrada, R., Gustilo, R.B. (1996) A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 78:512–523.
Schoifet, S.D., Morrey, B.F. (1990). Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 72:1383–1390.
Deirmengian, C., Greenbaum, J., Locke, P.A., Booth, R.E. Jr., Lonner, J.H. (2003). Limited success with open debridement and retention of components of acute Staphylococcus aureus infection after total knee arthroplasty. J Arthroplasty 18(7 Suppl I):22–26.
Crockarell, J.R., Hanssen, A.D., Osmon, D.R., Morrey, B.F. (1998). Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 80:1306–1313.
Berbari, E.F., Osmon, D.R., Duffy, M.C.T., Harmssen, W., Mandrekar, J.N., Hanssen, A.D., Steckelberg, J.M. (2006). Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 42: 216–223.
Marculescu, C.E., Berbari, E.F., Hanssen, A.D., Steckelberg, J.M., Harmsen, S.W., Mandrekar, J.N., Osmon, D.R. (2006). Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 42:471–478.
Barberàn, J., Aguilar, L., Carroquino, G., Gimenez, M.J., Sanchez, B., Martinez, D., Prieto, J. (2006). Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119:993e7–993e10.
Meehan, A.M., Osmon, D.R., Duffy, M.C.T., Keating, M.R. (2003). Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 36:845–849.
Zimmerli, W. (2006). Prosthetic joint infections. Best Prac Res Clin Rheum 20:1045–1063.
Windsor, R.E., Insall, J.N., Urs, W.K., Miller, D.V., Brause, R.D. (1990). Two-stage reimplantation for the salvage of total knee athroplasty complicated by infection. Further follow-up refinement of indications. J Bone Joint Surg Am 72:272–278.
Vielpeau, C. (2002). The management of infected hip prosthesis – a multicenter study of 563 cases: conclusions about surgical treatment. Rev Chir Orthop 88: (Suppl 5):214–216.
Langlais, F., Belot, N., Ropars, Thomazeau, H., Lambote, J.C., Cathelineau, G. (2006). Antibiotic cements in articular prosthesis: current orthopedic concepts. Internal J Antimicrob Agents 28:84–89.
Jackson, W.O., Schmalzried, T.P. (2000). Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 381:101–105.
Anguita-Alonso, P., Hanssen, A.D., Osmon, D.R., Trampuz, Steckelberg, J.M., Patel, R. (2005). High rate of aminoglycoside resistance among staphylococcus causing prosthetic joint inflammation. Clin Orthop Relat Res 439:43–47.
Silva, M., Tharani, R., Schmalzried, T.P. (2002). Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res 404:125–131.
Sponsellar, P.D., La Port, D.M., Hungerford, M.W., Eck, K., Bridewell, K.H., Lenke, L.G. (2000). Deep wound infections after neuromuscular scoliosis surgery: a multicenter study of risk factors and treatment outcomes. Spine 25:2461–246.
Glassman, S.D., Dimar, J.R., Puno, R.M., Johnson, J.R. (1996). Salvage of instrumental lumbar fusions complicated by surgical wound infection. Spine 21:2163–2169.
Zimmerli, W., Ochsner, P.E. (2003). Management of infection associated with prosthetic joints. Infection 31:99–105.
Laffer, R.R., Graber, P., Ochsner, P.E., Zimmerli, W. (2006). Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single center. Clin Microbiol Infect 12:433–439.
Fisman, D.N., Reilly, D.T., Karchmer, A.W., Goldie, S.J. (2001). Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty. Clin Infect Dis 32:419–430.
Mont, M.A., Waldman, B.J., Hungerford, D.S. (2000). Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am 82-A:1552–1557.
Lachiewicz, P.F., Rogers, G.D., Thomason, H.C. (1996). Aspiration of the hip joint before revision arthroplasty. Clinical and laboratory factors influencing attainment of a positive culture. J Bone Joint Surg Am 78:749–751.
Sendzik, J., Shakibaei, M., Schäfer-Korting, M., Stahlmann, R. (2005), Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 212:24–36.
Corps, AN, Harrall, R.L., Curry, V.A., Fenwick, SA., Hazleman, B.L., Riley, G., (2002), Ciprofloxacin enhances stimulation of matrix metalloproteinase 3 expression by interleukin- 1ßin human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arth Rheumatol 46:3034–3040.
Lehmann, W., Edgar, C.M., Wang, K., Cho., F.J., Barnes, G.L., Kakar, S., Graves, D.T., Rueger, J.M., Gerstenfeld, L.C., Einhorn, T.A. (2005), Tumor necrosis factor alpha (TNF-α) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36:300–310.
Stepensky, D., Kleinberg, L., Hoffman, A. (2003), Bone as an effect compartment. Models for uptake and release of drugs. Clin Pharmacokinet 42:863–881.
Lee, H.M., Ciancio, S.G., Tiiter, G., Ryan, M.E., Komaroff, E., Golub, L.M., (2004), Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drugs. J Periodontal 75:453–463.
Golub, L.M., Ramamuthy, N.S., Llavaneras, A., Ryan, M.E., Lee, H.M., Liu, Y., Bain, S., Sorsa, T. (1999), A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann. N.Y. Acad. Sci 878:290–310.
Greenwald, R.A., Moak, S.A., Ramamurthy, N.S., Golub, L.M. (1992), Tetracyclines suppress matrix metalloproteinases activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage, J Rheumatol 19:927–938.
Golub, L.M., Greenwald, R.A., Ramanurthy, N.S., McNamara, T.F., Rifkin, B.R. (1991), Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2:297–321.
Sasaki, t., Kaneko, H., Ramamurthy, N.S., Golub, L.M. (1991), Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat Rec 231:25–34.
Rifkin, B.R., Vernillo, A.T., Golub, L.M., Ramamurthy, N.S. (1994), Modulation of bone resorption by tetracyclines. Ann. N.Y. Acad. Sci. 732:165–180.
Zernicke, R.F., Wohl, G.R., Greenwald, R.A., Moak, S.A., Leng, W., Golub, L.M. (1997), Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. J Rheumatol 24:1324–1231.
Ruhe, J.J., Monson, T., Bradsher, R.W., Menon, A. (2005), Use of long-acting tetracyclines for methicillin-resistant. Staphylococcus aureus infection: case series and review of the literature. Clin Infect Dis 40:1429–1434.
Gosden, R.E., MacGowan, A.P., Bannister, G.C. (1998), Importance of air quality and related factors in the prevention of infection in orthopedic implant surgery. J Hosp Infect 39:173–180.
Al-Maiyah, M., Hill, D., Bajwa, A., Slater, S., Patil, P., Port, A., Gregg, P.J. (2005), Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br 87: 1256–1258.
Glenny. A.M., Song, F. (1999), Antimicrobial prophylaxis in total hip replacement: a systemic review. Health Technol Assess 3(21).
Suter, F., Avai, A., Fusco, U, Gerundini, M., Caprioli, S., Maggiolo, F. (1994), Teichoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbial Infect Dis 13:793–796.
Kalmeijer, M.D., Coertjens, H., van Nieuwland-Bollen, P.M., Bogaers-Hofman, D., deBaere, G.A.J., Stuur-man, A., van Belkum, A., Kluytmans, J.A.J.W. (2002), Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35:353–358.
Gillespie, W.J., WalenKamp, G. (2001), Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev (1):CD00–0244.
Josefsson, G., Gudmundsson, G., Kolmert, L., Wijkstrom, S. (1990), Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop 253:173–178.
Chiu, F.Y., Chen, E.M., Lin, C.F., Lo, W.H. (2002), Cefuroxime-impregnated cement in primary total knee orthoplasty: a prospective, randomized study of three hundred and forty knees. J Bone Jt Surg Am 84:759–762.
Josefsson, G., Kolmert, L. (1993), Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1688 hips. Clin Orthop 292: 210–214.
Herberts, P., Malchau, H., Garrelick, G., Swedish National Hip Arthroplasty Register. (2004), Annual Report 2004 (242,393 primary THR). Swed. Nat. Hip. Register. http:// www.jru.orthop.gu.se.
Engesaeter, L.B., Lie, S.A., Espehaug, B., Furnes, O., Vollset, S.E., Havelin, L.I. (2003), Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74:644–651.
Tramprz, A., Zimmerli, W. (2006), Antimicrobial agents in orthopedic surgery: Prophylaxis and treatment. Drugs 66:1089–1105.
American Academy of Orthopedic Surgeons. (2006), Antibiotic prophylaxis for dental patients with total joint replacements (Doc.no.-1014). Available from URL:http://www.aaos.org/wordht-ml/papers/advistmt./1014.htm.
American Academy of Orthopedic Surgeons. (2006), Antibiotic prophylaxis for urological patients with total joint replacements. (Doc. No. 1023). Available from URL: http://www.aa-os.org//wordhtml/papers/advistmt/1023.htm.
Scott. J.F., Morgan, D., Avent, M., Graves, S., Goss, A.N. (2005), Patients with artificial joints: do they need antibiotic cover for dental treatment? Austral Dent J 50 (4 Suppl 2): s45–s53.
Pommer, A., Muhr, G., David, A. (2002), Hydroxyapatate-coated Schanz pins in external fixations used for distraction osteogenesis: a randomized, controlled trial. J. Bone Jt Surg Am 84-A:1162–1166.
Parvizi, J., Wickstrom, E., Zeiger, A.R., Adams, C.S., Shapiro, I.M., Purtill, J.J., Sharkey, P. F., Hozak, W.J., Rothman, R.H., Hickok, N.J. (2004), Frank Stinchfield Award. Titanium surface with biologic activity against infection. Clin Orthop Relat Res 429:33–38.
Neut, D., Van de Belt, H., Stokroos, I., Van Horn, J.R., Van der Mei, H.C., Busscher, H.J. (2001), Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopedic revision surgery. J Antimicrob Chemther 47:885–891.
Wu, P., Grainger. D.W. (2006), Drug/device combination for local drug therapies and infection prophylaxis. Biomaterials 27:2450–2467.
Campoccia, D., Montanaro, L., Arciola, C.R. (2006), The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 27:2331–2339.
Shah, A., Mond, J., Walsh, S. (2004), Lysostaphin-coated catheters eradicate Staphylococcus aureus challenge and block surface colonization. Antimicrob Agents Chemother 48: 2704–2707.
El Helou, O.C., Berbari, E.F., Marculescu, C.E., El Atrouni, W.I., Razonable, R.R., Steckelberg, J.M., Hanssen, A.D., Osmon, D.R, (2008), Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy. Clin Infect Dis 47:903–909.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
(2009). Current Concepts of Orthopedic Implants and Prosthetic Joint Infections. In: Fong, I.W. (eds) Emerging Issues and Controversies in Infectious Disease. Emerging Infectious Diseases of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84841-9_12
Download citation
DOI: https://doi.org/10.1007/978-0-387-84841-9_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84840-2
Online ISBN: 978-0-387-84841-9
eBook Packages: MedicineMedicine (R0)